DSM-Firmenich AG

dsm-firmenich reports H1 2026 results

Press Release Ad hoc announcement pursuant to article 53 LR Kaiseraugst (Switzerland), Maastricht (Netherlands), July 30, 2026 dsm-firmenich reports H1 2026 resultsGood LFL sales growth and sequential margin improvement through first half Highlights Good like-for-like (LFL) sales growth of 5% in H1 2026, with 6% in Q2Adjusted EBITDA margin improved sequentially, with positive momentum into second halfContinued improvement in adjusted gross operating free cash flow2026-2028 action plan, aimed at

Yahoo Finance · 30/07/2026 · lire l'article ↗

Weekly progress on share repurchase program to cover share plans and reduce capital

Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), July 28, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 9, 2026 its intention to repurchase ordinary shares with an aggregate market value of €500 million and reduce its issued capital. On March 12, 2026, the company commenced repurchasing ordinary shares for a total amount of €540 million, of which €40 mill

Yahoo Finance · 28/07/2026 · lire l'article ↗

dsm-firmenich unveils SENSORIUM™ Seoul: Exploring Fragrance Creation & Ingredients for K-Beauty Futures

dsm-firmenich, innovators in nutrition, health, and beauty, announces the latest edition of SENSORIUM™, its flagship sensory experience designed to challenge conventions and explore the future of fragrance. Taking place in Seoul from June 22 to July 3, ATTENTION SEOUL: LIVING (IN)VISIBLE invites customers, partners and industry leaders in the region to discover how scent is becoming an increasingly powerful force in shaping identity, emotion and human connection.

Yahoo Finance · 18/06/2026 · lire l'article ↗

dsm-firmenich receives FDA approval on PARSOL® Shield, a new sun protection ingredient for the U.S.

Press Release dsm-firmenich receives FDA approval on PARSOL® Shield, a new sun protection ingredient for the U.S. Kaiseraugst (Switzerland), Maastricht (Netherlands), June 10, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announces the FDA approval of bemotrizinol (brand name: PARSOL® Shield) for the U.S. market, making it the first new sunscreen active ingredient approved in the United States in more than 25 years under modernized GRASE (Generally Recognized as Safe and Effec

Yahoo Finance · 10/06/2026 · lire l'article ↗

dsm-firmenich shares commence trading on SIX Swiss Exchange, establishing dual listing with Euronext Amsterdam

Press Release dsm-firmenich shares commence trading on SIX Swiss Exchange, establishing dual listing with Euronext Amsterdam Kaiseraugst (Switzerland), Maastricht (Netherlands), May 21, 2026 dsm-firmenich, innovators in nutrition, health and beauty, today announced the listing of its ordinary shares on SIX Swiss Exchange, in addition to its existing listing on Euronext Amsterdam. Trading on SIX Swiss Exchange commences today under the ticker symbol DSFIR. The dual listing strengthens the company

Yahoo Finance · 21/05/2026 · lire l'article ↗

DSM-Firmenich Medisca Deal Highlights U.S. Vitamin API And Valuation Upside

DSM-Firmenich (ENXTAM:DSFIR) has partnered with Medisca to expand access to pharmaceutical-grade vitamin active pharmaceutical ingredients in the U.S. market. The agreement focuses on supplying European-manufactured vitamin APIs to U.S. pharmaceutical compounding pharmacies. The partnership aims to broaden distribution channels and support higher quality standards in customized medications. For DSM-Firmenich, a company active in nutrition, health and beauty, this partnership provides a more...

Yahoo Finance · 14/05/2026 · lire l'article ↗